Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > News > pSivida Becomes Founding Member of the NASDAQ Health Care Index

July 29th, 2005

pSivida Becomes Founding Member of the NASDAQ Health Care Index

Abstract:
Global nanotechnology company pSivida Limited (ASX:PSD, NASDAQ:PSDV, Xetra:PSI) announced it has been made a founding member of the NASDAQ Health Care Index (IXHC).

Source:
businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

A Nanobiotechnology Startup from a small town in India attracts the Global Investors January 27th, 2019

Nanobiotix Plans to Conduct Registered Public Offering in the United States January 17th, 2019

Nanometrics to Participate in the 21st Annual Needham Growth Conference January 7th, 2019

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) December 18th, 2018

Nanomedicine

With nanopore sensing, VCU physics researchers detect subtle changes in single particles: The researchers' findings 'open the door to observe all kinds of interesting phenomenon on nanosurfaces,' an area of great interest to chemists February 21st, 2019

Platinum nanoparticles for selective treatment of liver cancer cells February 21st, 2019

What happens to magnetic nanoparticles once in cells? February 21st, 2019

Sensitive sensor detects Down syndrome DNA February 14th, 2019

Announcements

Synopsys and GLOBALFOUNDRIES Collaborate to Develop Industry’s First Automotive Grade 1 IP for 22FDX Process: Synopsys’ Portfolio of DesignWare Foundation, Analog, and Interface IP Accelerate ISO 26262 Qualification for ADAS, Powertrain, 5G, and Radar Automotive SoCs February 22nd, 2019

With nanopore sensing, VCU physics researchers detect subtle changes in single particles: The researchers' findings 'open the door to observe all kinds of interesting phenomenon on nanosurfaces,' an area of great interest to chemists February 21st, 2019

Platinum nanoparticles for selective treatment of liver cancer cells February 21st, 2019

What happens to magnetic nanoparticles once in cells? February 21st, 2019

Financial Reports

Arrowhead Pharmaceuticals to Webcast Fiscal 2019 First Quarter Results January 25th, 2019

Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 5, 2019 January 18th, 2019

Arrowhead Pharmaceuticals to Webcast 2018 Fiscal Year End Results November 27th, 2018

180 Degree Capital Corp. Reports Net Asset Value Per Share of $2.81 as of September 30, 2018; a Decrease of 3.4% From June 30, 2018 October 29th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project